Literature DB >> 35027815

Long-term efficacy and safety of repeated botulinum toxin a applications based on function and anesthesia type in children with cerebral palsy.

Murat Celal Sozbilen1, Kubra Evren Sahin2.   

Abstract

PURPOSE: This study evaluates the motor development of patients undergoing three or more repeated Botulinum toxin A (BoNT-A) applications in a tertiary pediatric hospital as well as the safety of three different types of anesthesia.
METHODS: Seventy-five children who underwent BoNT-A applications at least three consecutive times at six-month intervals and a total of 320 procedures were examined. Gross Motor Function Classification System (GMFCS) was employed in motor development evaluation. The three anesthesia methods (sedation analgesia, anesthesia with larengeal mask [LMA] and inhalation mask) were compared in terms of sedation, procedure, recovery, and total operation room time.
RESULTS: Following the procedures, significant motor development was observed in 60 (80%) patients. In sedation analgesia group during the first three procedures, the recovery time was seen to be significantly shorter, while there was no difference between the anesthesia methods of any procedures following the fourth. Regardless of the type of anesthesia, the recovery times of those having undergone six or more procedures were longer than those with less than six procedures.
CONCLUSIONS: As repeated BoNT-A application provides motor step progress, it can be applied safely and effectively under anesthesia. Sedation analgesia provides an easier recovery compared to LMA and mask only within the first three applications. However, recovery time increases with four or more repeated applications, specifically increasing as the number of applications increases. LEVEL OF EVIDENCE: III.
© 2021 Published by Elsevier B.V. on behalf of Professor P K Surendran Memorial Education Foundation.

Entities:  

Keywords:  Botulinum toxin; Cerebral palsy; Gross motor function; Repeated botulinum toxin; Sedation

Year:  2021        PMID: 35027815      PMCID: PMC8731691          DOI: 10.1016/j.jor.2021.12.005

Source DB:  PubMed          Journal:  J Orthop        ISSN: 0972-978X


  26 in total

1.  Early skill learning is expressed through selection and tuning of cortically represented muscle synergies.

Authors:  William J Kargo; Douglas A Nitz
Journal:  J Neurosci       Date:  2003-12-03       Impact factor: 6.167

2.  Conscious sedation or general anaesthetic for intramuscular botulinum toxin injections in children - a two centre cross-sectional prospective audit.

Authors:  M Forrester; J Srinivasan; S Mihrshahi; M Waugh; S O'Flaherty; J Rice; K Graham; A Scheinberg
Journal:  Eur J Paediatr Neurol       Date:  2011-08-16       Impact factor: 3.140

3.  Development and reliability of a system to classify gross motor function in children with cerebral palsy.

Authors:  R Palisano; P Rosenbaum; S Walter; D Russell; E Wood; B Galuppi
Journal:  Dev Med Child Neurol       Date:  1997-04       Impact factor: 5.449

4.  Botulinum toxin type A injections for treatment of spastic equinus in cerebral palsy: a secondary analysis of factors predictive of favorable response.

Authors:  Heli Sätilä; Heini Huhtala
Journal:  Am J Phys Med Rehabil       Date:  2010-11       Impact factor: 2.159

5.  Factors predicting the efficacy of botulinum toxin-A treatment of the lower limb in children with cerebral palsy.

Authors:  Elisa Fazzi; Ilaria Maraucci; Simona Torrielli; Francesco Motta; Giovanni Lanzi
Journal:  J Child Neurol       Date:  2005-08       Impact factor: 1.987

Review 6.  Efficacy of botulinum toxin A in children with cerebral palsy in Gross Motor Function Classification System levels IV and V: a systematic review.

Authors:  Tamis W Pin; Jessica Elmasry; Jenny Lewis
Journal:  Dev Med Child Neurol       Date:  2012-10-24       Impact factor: 5.449

Review 7.  Assessment and treatment of children with cerebral palsy.

Authors:  Gilbert Chan; Freeman Miller
Journal:  Orthop Clin North Am       Date:  2014-07       Impact factor: 2.472

8.  Long-term effects of botulinum toxin A in children with cerebral palsy.

Authors:  Kristina Tedroff; Fredrik Granath; Hans Forssberg; Yvonne Haglund-Akerlind
Journal:  Dev Med Child Neurol       Date:  2009-02       Impact factor: 5.449

9.  Therapeutic use of botulinum toxin in neurorehabilitation.

Authors:  Domenico Intiso
Journal:  J Toxicol       Date:  2011-09-14

Review 10.  Best clinical practice in botulinum toxin treatment for children with cerebral palsy.

Authors:  Walter Strobl; Tim Theologis; Reinald Brunner; Serdar Kocer; Elke Viehweger; Ignacio Pascual-Pascual; Richard Placzek
Journal:  Toxins (Basel)       Date:  2015-05-11       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.